Corient Private Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6K Sell
28,059
-28,059
-50% -$413K ﹤0.01% 2774
2025
Q4
$795K Buy
56,118
+28,059
+100% +$406K ﹤0.01% 2016
2025
Q3
$415K Hold
28,059
﹤0.01% 1917
2025
Q2
$425K Buy
28,059
+13,160
+88% +$192K ﹤0.01% 1791
2025
Q1
$215K Buy
14,899
+560
+4% +$8.56K ﹤0.01% 2035
2024
Q4
$217K Sell
14,339
-4,079
-22% -$65.6K ﹤0.01% 2074
2024
Q3
$303K Sell
18,418
-21,791
-54% -$357K ﹤0.01% 2005
2024
Q2
$660K Sell
40,209
-8,261
-17% -$133K ﹤0.01% 1503
2024
Q1
$791K Buy
+48,470
New +$751K ﹤0.01% 1405

Other funds holding BCAT

Corient Private Wealth's BCAT Position: Q1 2026 in Review

Corient Private Wealth reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 50% in Q1 2026, selling an estimated $413K and leaving 28,059 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Corient Private Wealth first reported a position in BCAT in Q1 2024 and has held it in 9 quarters since. The position peaked at $795K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Corient Private Wealth held 28,059 shares of BlackRock Capital Allocation Term Trust worth $28.6K as of Q1 2026.
  • Corient Private Wealth sold 28,059 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $413K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2774 holding.
  • Corient Private Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q1 2024 and has held it in 9 quarters since.
  • Corient Private Wealth's BlackRock Capital Allocation Term Trust position peaked at $795K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.